Eirgen Pharma
Pharmaceutical ManufacturingWaterford, Ireland51-200 Employees
Eirgen Pharma is a research-driven CDMO/CMO based in Waterford, Ireland, focusing on the development, manufacture, and supply of high potency oral solid dose products for human and veterinary medicines. The company supports the entire product lifecycle, from early-stage formulation development and clinical trial supply to large-scale manufacturing and packaging. It partners with specialty pharma firms and global innovators to deliver solutions that address complex development and manufacturing needs. With capabilities in high containment and high potency manufacturing, Eirgen aims to manage challenging molecules safely while maintaining regulatory compliance across worldwide markets. In 2025, the company announced plans to launch a new manufacturing facility intended to raise annual capacity to more than 500 million units. In March 2026, the newly constructed Waterford facility received HPRA approval, indicating regulatory validation of the expansion.